HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.

AbstractCONTEXT:
Xiaoyaosan decoction (XYS), a classical Traditional Chinese Medicine (TCM) formula is used to treat liver fibrosis in clinics.
OBJECTIVE:
This study explores defined compound combinations from XYS decoction to treat liver fibrosis.
MATERIALS AND METHODS:
Network pharmacology combined with transcriptomics analysis was used to analyze the XYS decoction and liver depression and spleen deficiency syndrome liver fibrosis. From the constructed XYS-Syndrome-liver fibrosis network, the top 10 active formulas were developed by topological analysis according to network stability. The most active formula was determined by in vitro study. The anti-fibrosis effect was evaluated by in vitro and in vivo studies.
RESULTS:
According to the network XYS-Syndrome-liver fibrosis network, 8 key compounds and 255 combinations were predicted from in XYS. Luteolin, licochalcone A, aloe-emodin and acacetin formula (LLAAF) had a synergistic effect on the proliferation inhibition of hepatic stellate cells compared to individual compounds alone. The treatment of XYS and LLAAF showed a similar anti-liver fibrotic effect that reduced histopathological changes of liver fibrosis, Hyp content and levels of α-SMA and collagen I in CCl4-induced liver fibrosis in rats. Transcriptomics analysis revealed LLAAF regulated PI3K-Akt, AMPK, FoxO, Jak-STAT3, P53, cell cycle, focal adhesion, and PPAR signalling. Furthermore, LLAAF was confirmed to regulate Jak-STAT and PI3K-Akt-FoxO signalling in vitro and in vivo.
CONCLUSIONS:
This study developed a novel anti-liver formula LLAAF from XYS, and demonstrated its anti-liver fibrotic activity which may be involved in the regulation of Jak-STAT and PI3K-Akt-FoxO signalling.
AuthorsYuan Zhou, Rong Wu, Fei-Fei Cai, Wen-Jun Zhou, Yi-Yu Lu, Hui Zhang, Qi-Long Chen, Ming-Yu Sun, Shi-Bing Su
JournalPharmaceutical biology (Pharm Biol) Vol. 59 Issue 1 Pg. 1594-1606 (Dec 2021) ISSN: 1744-5116 [Electronic] England
PMID34808067 (Publication Type: Journal Article)
Chemical References
  • Anthraquinones
  • Chalcones
  • Drugs, Chinese Herbal
  • Flavones
  • xiaoyaosan
  • aloe emodin
  • licochalcone A
  • Luteolin
  • acacetin
Topics
  • Animals
  • Anthraquinones (administration & dosage, pharmacology)
  • Cell Line
  • Chalcones (administration & dosage, pharmacology)
  • Drug Synergism
  • Drugs, Chinese Herbal (administration & dosage, chemistry, pharmacology)
  • Flavones (administration & dosage, pharmacology)
  • Hepatic Stellate Cells (drug effects, pathology)
  • Humans
  • Liver Cirrhosis (drug therapy)
  • Luteolin (administration & dosage, pharmacology)
  • Male
  • Network Pharmacology
  • Rats
  • Rats, Wistar
  • Signal Transduction (drug effects)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: